Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Synergy CHC (SNYR) Gains from Investment Securities (2016 - 2025)

Historic Gains from Investment Securities for Synergy CHC (SNYR) over the last 10 years, with Q3 2025 value amounting to $1.5 million.

  • Synergy CHC's Gains from Investment Securities rose 33199.84% to $1.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.5 million, marking a year-over-year increase of 33199.84%. This contributed to the annual value of $4799.0 for FY2024, which is 8367.74% down from last year.
  • Latest data reveals that Synergy CHC reported Gains from Investment Securities of $1.5 million as of Q3 2025, which was up 33199.84% from $252102.0 recorded in Q2 2025.
  • Synergy CHC's Gains from Investment Securities' 5-year high stood at $1.5 million during Q3 2025, with a 5-year trough of -$2400.0 in Q2 2024.
  • Moreover, its 3-year median value for Gains from Investment Securities was $129754.5 (2023), whereas its average is $342091.0.
  • Over the last 5 years, Synergy CHC's Gains from Investment Securities had its largest YoY gain of 1060425.0% in 2025, and its largest YoY loss of 33199.84% in 2025.
  • Over the past 3 years, Synergy CHC's Gains from Investment Securities (Quarter) stood at $7407.0 in 2023, then skyrocketed by 4438.09% to $336136.0 in 2024, then skyrocketed by 332.0% to $1.5 million in 2025.
  • Its last three reported values are $1.5 million in Q3 2025, $252102.0 for Q2 2025, and $336136.0 during Q3 2024.